
Government warned over test and trace as UK schools prep to reopen
Newsletters and Deep Dive digital magazine
The PMi Awards 2025 – formerly known as the PM Society Digital Awards – celebrated its inaugural edition under its new name at The Brewery in London on 11th September.
Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Amy Burroughs, CEO, Terns Pharmaceuticals, discusses available treatments for CML, the potential of allosteric TKIs, and the wider oncology landscape.
Developments in the oncology space in 2024 brought hope to both industry and patients.
Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
Advancing Analytics & QC from Pre-IND to BLA